Found: 118
Select item for more details and to access through your institution.
Pharmacogenetics of warfarin and healthcare costs – Real‐world data analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 3, p. 382, doi. 10.1002/pds.5585
- By:
- Publication type:
- Article
THE FINE STRUCTURE OF THE SPINDLE CELL IN KAPOSI'S SARCOMA.
- Published in:
- APMIS, 1965, v. 63, n. 4, p. 567, doi. 10.1111/apm.1965.63.4.567
- By:
- Publication type:
- Article
AN ANGIOGRAPHIC STUDY OF CADMIUM-INDUCED VASCULAR LESIONS IN THE TESTIS AND EPIDIDYMIS OF THE RAT.
- Published in:
- APMIS, 1965, v. 63, n. 4, p. 513, doi. 10.1111/apm.1965.63.4.513
- By:
- Publication type:
- Article
THE DISTRIBUTION OF LACTATE AND NADH TETRAZOLIUM REDUCTASE.
- Published in:
- APMIS, 1964, v. 61, n. 2, p. 243, doi. 10.1111/apm.1964.61.2.243
- By:
- Publication type:
- Article
Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: A Finnish nationwide cohort study .
- Published in:
- Pharmacology Research & Perspectives, 2022, v. 10, n. 3, p. 1, doi. 10.1002/prp2.961
- By:
- Publication type:
- Article
Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190272
- By:
- Publication type:
- Article
PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 6, p. 1044, doi. 10.1038/clpt.2011.336
- By:
- Publication type:
- Article
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 6, p. 565, doi. 10.1016/j.clpt.2006.09.003
- By:
- Publication type:
- Article
SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 4, p. 356, doi. 10.1016/j.clpt.2006.06.010
- By:
- Publication type:
- Article
Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 5, p. 419, doi. 10.1016/j.clpt.2006.01.010
- By:
- Publication type:
- Article
Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 3, p. 231, doi. 10.1016/j.clpt.2005.11.002
- By:
- Publication type:
- Article
Cyclosporine markedly raises the plasma concentrations of repaglinide
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 4, p. 388, doi. 10.1016/j.clpt.2005.07.005
- By:
- Publication type:
- Article
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 6, p. 468, doi. 10.1016/j.clpt.2005.01.018
- By:
- Publication type:
- Article
Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 3, p. 239, doi. 10.1016/j.clpt.2004.05.001
- By:
- Publication type:
- Article
Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 4, p. 380, doi. 10.1016/S0009-9236(03)00228-5
- By:
- Publication type:
- Article
Effect of fluconazole on the pharmacokinetics and pharmacodynamics of nateglinide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 25, doi. 10.1016/S0009-9236(03)00089-4
- By:
- Publication type:
- Article
Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 4, p. 362, doi. 10.1067/mcp.2002.127397
- By:
- Publication type:
- Article
Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 72, n. 3, p. 326, doi. 10.1067/mcp.2002.127495
- By:
- Publication type:
- Article
Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 5, p. 439, doi. 10.1016/S0009-9236(01)84578-1
- By:
- Publication type:
- Article
The cytochrome P4503A4 inhibitor clarithromycin increases the plasma concentrations and effects of repaglinide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 70, n. 1, p. 58, doi. 10.1067/mcp.2001.116511
- By:
- Publication type:
- Article
Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 6, p. 400, doi. 10.1067/mcp.2001.115822
- By:
- Publication type:
- Article
Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 4, p. 194, doi. 10.1067/mcp.2001.114229
- By:
- Publication type:
- Article
Rifampin decreases the plasma concentrations and effects of repaglinide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 68, n. 5, p. 495, doi. 10.1067/mcp.2000.111183
- By:
- Publication type:
- Article
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
- Published in:
- Human Genomics, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s40246-024-00579-8
- By:
- Publication type:
- Article
Drug‐related deaths in a university hospital: Comparison to previous decades.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 1, p. 165, doi. 10.1111/bcpt.13951
- By:
- Publication type:
- Article
Inhibition of efflux transporters by poly ADP‐ribose polymerase inhibitors.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 4, p. 428, doi. 10.1111/bcpt.13928
- By:
- Publication type:
- Article
CYP3A4*22 may increase bleeding risk in ticagrelor users.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 133, n. 2, p. 202, doi. 10.1111/bcpt.13884
- By:
- Publication type:
- Article
Toxicity and therapy outcome associations in LIG3, SLCO1B3, ABCB1, OPRM1 and GSTP1 in high‐grade serous ovarian cancer.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2023, v. 132, n. 6, p. 521, doi. 10.1111/bcpt.13866
- By:
- Publication type:
- Article
Professor Pertti Jaakko Neuvonen (25 August 1943‐14 May 2020).
- Published in:
- 2021
- By:
- Publication type:
- Obituary
Interactions of (2S,6S;2R,6R)‐Hydroxynorketamine, a Secondary Metabolite of (R,S)‐Ketamine, with Morphine.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2018, v. 122, n. 5, p. 481, doi. 10.1111/bcpt.12941
- By:
- Publication type:
- Article
Effects of Genetic Variants on Carboxylesterase 1 Gene Expression, and Clopidogrel Pharmacokinetics and Antiplatelet Effects.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2018, v. 122, n. 3, p. 341, doi. 10.1111/bcpt.12916
- By:
- Publication type:
- Article
Do Diuretics have Antinociceptive Actions: Studies of Spironolactone, Eplerenone, Furosemide and Chlorothiazide, Individually and with Oxycodone and Morphine.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2017, v. 120, n. 1, p. 38, doi. 10.1111/bcpt.12634
- By:
- Publication type:
- Article
High Frequency of CYP2D6 Ultrarapid Metabolizer Genotype in the Finnish Population.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2016, v. 119, n. 3, p. 291, doi. 10.1111/bcpt.12590
- By:
- Publication type:
- Article
Drug-Related Inadvertent Deaths in a University Hospital -- A Declining Trend.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2015, v. 117, n. 6, p. 421, doi. 10.1111/bcpt.12435
- By:
- Publication type:
- Article
Gender, but not CYP7A1 or SLCO1B1 Polymorphism, Affects the Fasting Plasma Concentrations of Bile Acids in Human Beings.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2012, v. 110, n. 3, p. 245, doi. 10.1111/j.1742-7843.2011.00792.x
- By:
- Publication type:
- Article
Frequencies of Single-Nucleotide Polymorphisms of SLCO1A2, SLCO1B3 and SLCO2B1 Genes in a Finnish Population.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2011, v. 108, n. 1, p. 9, doi. 10.1111/j.1742-7843.2010.00605.x
- By:
- Publication type:
- Article
SLCO1B1 Polymorphism and Oral Antidiabetic Drugs.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2010, v. 107, n. 4, p. 775, doi. 10.1111/j.1742-7843.2010.00581.x
- By:
- Publication type:
- Article
Extracting Canopy Surface Texture from Airborne Laser Scanning Data for the Supervised and Unsupervised Prediction of Area-Based Forest Characteristics.
- Published in:
- Remote Sensing, 2016, v. 8, n. 7, p. 582, doi. 10.3390/rs8070582
- By:
- Publication type:
- Article
Prediction of Forest Stand Attributes Using TerraSAR-X Stereo Imagery.
- Published in:
- Remote Sensing, 2014, v. 6, n. 4, p. 3227, doi. 10.3390/rs6043227
- By:
- Publication type:
- Article
Vegan diet in young children remodels metabolism and challenges the statuses of essential nutrients.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 2, p. 1, doi. 10.15252/emmm.202013492
- By:
- Publication type:
- Article
Incidence, preventability, and causality of adverse drug reactions at a university hospital emergency department.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 4, p. 643, doi. 10.1007/s00228-020-03043-3
- By:
- Publication type:
- Article
Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 681, doi. 10.1007/s00228-011-1158-5
- By:
- Publication type:
- Article
No significant effect of the SLCO1B1 polymorphism on the pharmacokinetics of ursodeoxycholic acid.
- Published in:
- European Journal of Clinical Pharmacology, 2011, v. 67, n. 11, p. 1159, doi. 10.1007/s00228-011-1070-z
- By:
- Publication type:
- Article
Effect of ABCB1 haplotypes on the pharmacokinetics and renin-inhibiting effect of aliskiren.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 9, p. 865, doi. 10.1007/s00228-010-0836-z
- By:
- Publication type:
- Article
Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 5, p. 497, doi. 10.1007/s00228-010-0796-3
- By:
- Publication type:
- Article
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 5, p. 463, doi. 10.1007/s00228-007-0273-9
- By:
- Publication type:
- Article
Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 7, p. 503, doi. 10.1007/s00228-006-0136-9
- By:
- Publication type:
- Article
Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 6, p. 409, doi. 10.1007/s00228-006-0123-1
- By:
- Publication type:
- Article
Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide.
- Published in:
- European Journal of Clinical Pharmacology, 2006, v. 62, n. 6, p. 463, doi. 10.1007/s00228-006-0133-z
- By:
- Publication type:
- Article
Postoperative oxycodone in breast cancer surgery: What factors associate with analgesic plasma concentrations?
- Published in:
- Scandinavian Journal of Pain, 2016, v. 12, n. 1, p. 118, doi. 10.1016/j.sjpain.2016.05.009
- By:
- Publication type:
- Article